医学综述
醫學綜述
의학종술
Medical Recapitulate
2015年
18期
3283-3285
,共3页
屈园园(综述)%余锂镭%江洪(审校)
屈園園(綜述)%餘鋰鐳%江洪(審校)
굴완완(종술)%여리뢰%강홍(심교)
缺血/再灌注损伤%心肌细胞%线粒体
缺血/再灌註損傷%心肌細胞%線粒體
결혈/재관주손상%심기세포%선립체
Ischemia/reperfusion injury%Myochardium%Mitochondria
近年来,我国急性心肌梗死发病率明显上升,已接近国际平均水平。心肌缺血/再灌注损伤( I/RI)是缺血心肌恢复血运后的常见并发症。研究表明,I/RI与线粒体功能结构损害关系密切。心肌发生缺血/再灌注时,心肌细胞发生一系列病理生理变化。迄今为止,已发现多种手段可用来减弱I/RI,该保护通路包括乙酰胆碱、一氧化氮合酶、一氧化氮、内皮细胞、蛋白激酶 Cε、线粒体连接蛋白43、线粒体ATP敏感性钾离子通道。
近年來,我國急性心肌梗死髮病率明顯上升,已接近國際平均水平。心肌缺血/再灌註損傷( I/RI)是缺血心肌恢複血運後的常見併髮癥。研究錶明,I/RI與線粒體功能結構損害關繫密切。心肌髮生缺血/再灌註時,心肌細胞髮生一繫列病理生理變化。迄今為止,已髮現多種手段可用來減弱I/RI,該保護通路包括乙酰膽堿、一氧化氮閤酶、一氧化氮、內皮細胞、蛋白激酶 Cε、線粒體連接蛋白43、線粒體ATP敏感性鉀離子通道。
근년래,아국급성심기경사발병솔명현상승,이접근국제평균수평。심기결혈/재관주손상( I/RI)시결혈심기회복혈운후적상견병발증。연구표명,I/RI여선립체공능결구손해관계밀절。심기발생결혈/재관주시,심기세포발생일계렬병리생리변화。흘금위지,이발현다충수단가용래감약I/RI,해보호통로포괄을선담감、일양화담합매、일양화담、내피세포、단백격매 Cε、선립체련접단백43、선립체ATP민감성갑리자통도。
The incidence of acute myocardial infarction has been ascending notably in recent years and is reaching international average.Myocardial ischemia/reperfusion injury(I/RI) is a common complication after recover of the blood supply in ischemic myocardium.Studies show that I/RI is closely associated with impairment of mitochondrial function and structure .Cardiomyocytes suffer from a series of pathophysiological changes when ischemia/reperfusion occurs in myocardial infarction.So far multiple measures have been dis-covered to attenuate I/RI.This protective pathway includes acetylcholine,nitrogen monoxide synthase,nitro-gen monoxide, protein kinase Cε, mitochondrial connexin 43 and mitochondrial ATP sensitive potassium channel.